Conference item icon

Conference item

Effect of ribavirin and interferon on the outcome of critically ill patients with mers

Abstract:
Interferon and ribavirin have been used in the treatment of the Middle East Respiratory Syndrome (MERS), but the efficacy of this therapy remains uncertain. Existing data are limited by the lack of adjustment to time-dependent covariates at the time of initiation of therapy. This study objective is to examine the association of ribavirin/interferon in critically ill MERS patients using marginal structural models.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors


Publisher:
American Thoracic Society
Host title:
American Thoracic Society (ATS) 2017 International Conference
Journal:
American Thoracic Society (ATS) 2017 International Conference More from this journal
Publication date:
2017-05-01
ISSN:
1073-449X


Pubs id:
pubs:718422
UUID:
uuid:4d5543b3-8e35-4c2d-ae22-875dd42e6dc3
Local pid:
pubs:718422
Source identifiers:
718422
Deposit date:
2017-08-17
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP